EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma

Wenhao Lu, Yixuan Liu, Jizhen Cen, Shengzhu Huang, Zheng Wen, Jiaping Li, Zengnan Mo, Xuefang Liang, Zheng Lu, Cheng Su, Zhenyuan Yu iD

Cancer Science · 2025

DOI: 10.1111/cas.70220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Wenhao Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Single-Cell Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, China Postdoctoral Science Foundation, Youth Science Foundation of Guangxi Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) with sarcomatoid differentiation is a rare histological type of ccRCC, characterized by aggressive clinical behavior and poor prognosis. However, the malignant characteristics of this disease have yet to be fully elucidated. Here, we performed single‐cell RNA sequencing (scRNA‐seq), single‐cell assay for transposase‐accessible chromatin using sequencing (scATAC‐seq), and WES analysis on a single patient with sarcomatoid ccRCC. By integrating scRNA‐seq and scATAC‐seq data from 19 previous classical ccRCC samples (19,819 tumor cells and 21,684 nuclei), we firstly identified the transcriptional regulatory features of sarcomatoid differentiated tumor cells by scATAC‐seq, primarily evidenced by active binding with FOS / JUND , FOSL1 / JUN , and FOSL2 . In addition, we identified DST , FRMD4A , and PREX2 as tumor markers for ccRCC with sarcomatoid differentiation, which were validated in a cohort study. Moreover, we determined that PREX2 played a malignant role in ccRCC with sarcomatoid differentiation in vitro and in vivo, facilitating tumor progression by inhibiting PTEN and activating the PI3K/AKT pathway. This study demonstrated the comprehensive gene expression and DNA regulation information of ccRCC with sarcomatoid differentiation, highlighting its malignant characteristics, thereby offering novel insights for the diagnosis and treatment of sarcomatoid ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsSingle-Cell AnalysisHumansAnimalsMiceGene Expression Regulation, NeoplasticBiomarkers, TumorCell Line, TumorPTEN PhosphohydrolaseRNA-SeqMaleFemaleSequence Analysis, RNACell DifferentiationSingle-Cell Gene Expression Analysis

Stichwörter der Autor:innen

clear cell renal cell carcinomamalignant characteristicssarcomatoid differentiationscATAC‐seqscRNA‐seq

Substanzen

Biomarkers, TumorPTEN PhosphohydrolasePTEN protein, human

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China.
  • Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nann…
  • Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China.
  • Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China.

ORCID-Profile: Zhenyuan Yu

Förderung

  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • China Postdoctoral Science Foundation
  • Youth Science Foundation of Guangxi Medical University

Zitieren

APA

Lu, W., Liu, Y., Cen, J., Huang, S., Wen, Z., Li, J., Mo, Z., Liang, X., Lu, Z., Su, C., & Yu, Z. (2025). Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma. Cancer Science. https://doi.org/10.1111/cas.70220

Vancouver

Lu W, Liu Y, Cen J, Huang S, Wen Z, Li J, et al. Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma. Cancer Science. 2025. doi:10.1111/cas.70220

BibTeX
@article{Lu2025,
  author = {Lu, Wenhao and Liu, Yixuan and Cen, Jizhen and Huang, Shengzhu and Wen, Zheng and Li, Jiaping and Mo, Zengnan and Liang, Xuefang and Lu, Zheng and Su, Cheng and Yu, Zhenyuan},
  title = {Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.70220}
}
Kostenlos starten →